NF‐κB not only enhances ABCG2 transcription but also promotes its membrane localization, facilitating the development of multidrug resistance (MDR) in various cancers, including acute myeloid leukemia and non‐small cell lung cancer (NSCLC) [42, 43]. Here, NFKB1 is linked to lung cancer.